Skip to main content

Dr. Greg E. Gin, MD

Urology (Urology Physician)

5901 E 7th St Bldg 126
Long Beach, CA 90822

Who else practices at this address →

Los Angeles County includes primary care (7% of residents) and mental health (13% of residents) shortage areas. About shortage areas

Call (562) 826-5434

  • Medicare participating

At a glance

Years since graduation
16
In the NPI registry since
2010
Medicare patients seen, 2024
100

Licensed in California since 2015, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is

Education and training

  • 2010Registered with an NPI (national billing number; not a license date)

Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Urology Physician primary
    CA license A136431 (first issued 2015; current)

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Urology per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
100
Services billed
274
Patients’ average age
73
Most frequent Medicare services, 2023
ServiceTimesPatients
Established patient office or other outpatient visit, 20-29 minutes9263
Established patient office or other outpatient visit, 30-39 minutes2920
Ultrasound scan of pelvic region through rectum2119
Biopsy of prostate gland1919

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 4 companies reported 14 payments worth $2,895 in total to this clinician.

By company
Intuitive Surgical, Inc.$2,633
Calyxo, Inc.$226
Laborie Medical Technologies Corp.$18.88
Urgo Medical North America, LLC$17.14
By type
Education$1,500
Travel and Lodging$958
Food and Beverage$437

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Nov 21, 2025Intuitive Surgical, Inc.
Nov 21, 2025
Education
DA VINCI SP · SURGERY · in-kind
$1,500
Oct 30, 2025Intuitive Surgical, Inc.
Oct 30, 2025
Travel and Lodging
Da Vinci Surgical System · SURGERY · travel to SAN JOSE, CA · in-kind
$481
Nov 3, 2025Intuitive Surgical, Inc.
Nov 3, 2025
Travel and Lodging
Da Vinci Surgical System · SURGERY · travel to SANTA CLARA, CA · in-kind
$352
Nov 21, 2025Intuitive Surgical, Inc.
Nov 21, 2025
Travel and Lodging
Da Vinci Surgical System · SURGERY · travel to SAN JOSE, CA · in-kind
$95.65
Oct 30, 2025Intuitive Surgical, Inc.
Oct 30, 2025
Travel and Lodging
Da Vinci Surgical System · SURGERY · travel to SAN JOSE, CA · in-kind
$30.00

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in California →

Industry-funded research

Named as a principal investigator on 4 industry-funded studies in 2025, from 2 companies. The companies reported $59,156 in research payments for these studies, mostly to the institutions running them.

  • A Phase 3, Open-Label, Multi-Center, Randomized Study Evaluating the Efficacy and Safety of TAR-200 in Combination with Cetrelimab Versus Intravesical Bacillus CalmetteGurin (BCG) in Participants with BCG-nave High-Ri…
    Janssen Research & Development, LLC
  • URO-013
    Myriad Genetic Laboratories, Inc.
  • A Phase 3, Open-Label, Multi-Center, Randomized Study Evaluating the Efficacy and Safety of TAR-200 in Combination with Cetrelimab Versus Intravesical Bacillus CalmetteGurin (BCG) in Participants with BCG-nave High-Ri…
    Janssen Research & Development, LLC
  • A Phase 3, Open-Label, Multi-Center, Randomized Study Evaluating the Efficacy and Safety of TAR-200 in Combination with Cetrelimab Versus Intravesical Bacillus CalmetteGurin (BCG) in Participants with BCG-nave High-Ri…
    Janssen Research & Development, LLC

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Urology clinicians in Long Beach

Sources

NPI registry (CMS NPPES, November 2026; record last updated March 17, 2018), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1699091850. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.